Pinnacle Associates’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,728
| Closed | -$124K | – | 824 |
|
|
2023
Q3 | $124K | Sell |
5,728
-244
| -4% | -$9.58K | ﹤0.01% | 778 |
|
|
2023
Q2 | $403K | Sell |
5,972
-153
| -2% | -$63.3K | 0.01% | 610 |
|
|
2023
Q1 | $2.86M | Sell |
6,125
-64
| -1% | -$33.9K | 0.06% | 265 |
|
|
2022
Q4 | $2.48M | Sell |
6,189
-160
| -3% | -$61.3K | 0.05% | 270 |
|
|
2022
Q3 | $2.06M | Sell |
6,349
-316
| -5% | -$102K | 0.05% | 280 |
|
|
2022
Q2 | $1.76M | Sell |
6,665
-770
| -10% | -$197K | 0.04% | 318 |
|
|
2022
Q1 | $2.23M | Sell |
7,435
-253
| -3% | -$88.2K | 0.04% | 329 |
|
|
2021
Q4 | $2.71M | Sell |
7,688
-966
| -11% | -$301K | 0.05% | 300 |
|
|
2021
Q3 | $2.21M | Sell |
8,654
-350
| -4% | -$124K | 0.04% | 326 |
|
|
2021
Q2 | $6M | Sell |
9,004
-131
| -1% | -$75.5K | 0.11% | 193 |
|
|
2021
Q1 | $7.93M | Sell |
9,135
-795
| -8% | -$846K | 0.15% | 154 |
|
|
2020
Q4 | $9.21M | Sell |
9,930
-538
| -5% | -$566K | 0.19% | 133 |
|
|
2020
Q3 | $10.8M | Sell |
10,468
-369
| -3% | -$397K | 0.26% | 106 |
|
|
2020
Q2 | $11M | Sell |
10,837
-48
| -0.4% | -$44.6K | 0.27% | 102 |
|
|
2020
Q1 | $9.46M | Sell |
10,885
-1,537
| -12% | -$1.53M | 0.29% | 100 |
|
|
2019
Q4 | $13.3M | Sell |
12,422
-878
| -7% | -$896K | 0.29% | 95 |
|
|
2019
Q3 | $12.3M | Sell |
13,300
-515
| -4% | -$566K | 0.29% | 94 |
|
|
2019
Q2 | $15.6M | Sell |
13,815
-1,154
| -8% | -$1.26M | 0.37% | 75 |
|
|
2019
Q1 | $20.3M | Sell |
14,969
-256
| -2% | -$347K | 0.46% | 59 |
|
|
2018
Q4 | $17.6M | Sell |
15,225
-663
| -4% | -$745K | 0.45% | 61 |
|
|
2018
Q3 | $24.1M | Sell |
15,888
-2,391
| -13% | -$3.68M | 0.5% | 56 |
|
|
2018
Q2 | $28.6M | Sell |
18,279
-3,098
| -14% | -$4.04M | 0.59% | 48 |
|
|
2018
Q1 | $24.7M | Sell |
21,377
-952
| -4% | -$1.25M | 0.48% | 55 |
|
|
2017
Q4 | $26.5M | Sell |
22,329
-1,989
| -8% | -$2.49M | 0.51% | 55 |
|
|
2017
Q3 | $32.7M | Sell |
24,318
-691
| -3% | -$728K | 0.6% | 47 |
|
|
2017
Q2 | $20.2M | Sell |
25,009
-1,069
| -4% | -$745K | 0.39% | 76 |
|
|
2017
Q1 | $16.1M | Sell |
26,078
-1,101
| -4% | -$671K | 0.31% | 91 |
|
|
2016
Q4 | $14.5M | Sell |
27,179
-1,499
| -5% | -$748K | 0.29% | 96 |
|
|
2016
Q3 | $14.8M | Sell |
28,678
-470
| -2% | -$221K | 0.3% | 94 |
|
|
2016
Q2 | $12M | Sell |
29,148
-243
| -0.8% | -$111K | 0.26% | 111 |
|
|
2016
Q1 | $15.6M | Buy |
29,391
+1,417
| +5% | +$706K | 0.33% | 83 |
|
|
2015
Q4 | $21.3M | Sell |
27,974
-1,526
| -5% | -$1.01M | 0.45% | 67 |
|
|
2015
Q3 | $16.2M | Sell |
29,500
-526
| -2% | -$319K | 0.36% | 71 |
|
|
2015
Q2 | $17.6M | Buy |
+30,026
| New | +$17.5M | 0.33% | 82 |
|
Other funds holding KYNB
AC
Pinnacle Associates's KYNB Position: Q4 2023 in Review
Pinnacle Associates sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 5,728 shares — an estimated $124K sold.
Pinnacle Associates first reported a position in KYNB in Q2 2015 and held it in 34 quarters. The position peaked at $32.7M in Q3 2017. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.
- Pinnacle Associates reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
- Pinnacle Associates sold 5,728 Kyntra Bio shares in Q4 2023, an estimated $124K.
- Pinnacle Associates first reported a position in Kyntra Bio in Q2 2015 and held it in 34 quarters.
- Pinnacle Associates's Kyntra Bio position peaked at $32.7M in Q3 2017.
- 100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.
Based on Pinnacle Associates's 13F filing for Q4 2023, filed 19 Jan 2024.